The Cancer Letter

Inside information on cancer research and drug development

Vol.
24
No.
4
April 27, 2001Apr 27, 2001
Free
DOWNLOAD THE PDF

Promising Results For Glivec In CML Continue, FDA Grants Priority Review

High Response Rate of Hairy Cell Leukemia Patients to Immunotoxin Treatment In Phase I

Wilms’ Tumor Survivors At High Risk Of Heart Failure

Cancer Pain Treatment Guide Published By NCCN, ACS

Without Advance Directives, Families Prolong Treatment

Long-Term Estrogen Use May Increase Ovarian Cancer Risk

Natural Substance Blocks Androgen Activity In Vitro

NCI-Approved Clinical Trials Listed For Month Of March

Login

Site license subscribers:
Log in with your IP | Register a sponsored account